Literature DB >> 16926966

Medicinal marijuana use: experiences of people with multiple sclerosis.

Stacey A Page1, Marja J Verhoef.   

Abstract

OBJECTIVE: To describe medical marijuana use from the perspectives of patients with multiple sclerosis.
DESIGN: A qualitative, descriptive design was used. Participants discussed their medicinal marijuana use in one-to-one, semistructured interviews.
SETTING: Interviews were conducted at a time and place convenient to participants. PARTICIPANTS: Six men and eight women with multiple sclerosis participated.
METHOD: Potential participants identified themselves to the researcher after receiving an invitation in a mailed survey. Eligibility was confirmed, and purposive sampling was used to recruit subjects. A range of issues emerged from the interviews. Interviews and data analysis continued until saturation occurred. MAIN
FINDINGS: Descriptions fell into three broad areas: patterns of use, legal or social concerns, and perceived effects. Consumption patterns ranged from very infrequent to very regular and were influenced by symptoms, social factors, and supply. Legal concerns expressed by most respondents were negligible. Social concerns centred on to whom use was revealed. The perceived benefits of use were consistent with previous reports in the literature: reduction in pain, spasms, tremors, nausea, numbness, sleep problems, bladder and bowel problems, and fatigue and improved mood, ability to eat and drink, ability to write, and sexual functioning. Adverse effects included problems with cognition, balance, and fatigue and the feeling of being high. Although participants described risks associated with using marijuana, the benefits they derived made the risks acceptable.
CONCLUSION: Further research is needed to clarify the safety and efficacy of marijuana use by patients with multiple sclerosis. If evidence of benefit is seen, medicinal marijuana should be made available to patients who could benefit from it. Until then, discussing medicinal marijuana use with patients will be awkward for health professionals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16926966      PMCID: PMC1479734     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  25 in total

1.  Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis.

Authors:  F Schon; P E Hart; T L Hodgson; A L Pambakian; M Ruprah; E M Williamson; C Kennard
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

Review 2.  Whatever happened to qualitative description?

Authors:  M Sandelowski
Journal:  Res Nurs Health       Date:  2000-08       Impact factor: 2.228

3.  A primer for patients' use of medicinal marijuana.

Authors:  B Sibbald
Journal:  CMAJ       Date:  2001-08-07       Impact factor: 8.262

Review 4.  Multiple sclerosis: emerging opportunities for therapeutic intervention.

Authors:  C F Evans; L P Shriver
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2002-02

5.  Cannabis use for chronic non-cancer pain: results of a prospective survey.

Authors:  Mark A Ware; Crystal R Doyle; Ryan Woods; Mary E Lynch; Alexander J Clark
Journal:  Pain       Date:  2003-03       Impact factor: 6.961

6.  Who is using cannabis as a medicine and why: an exploratory study.

Authors:  A C Ogborne; R G Smart; T Weber; C Birchmore-Timney
Journal:  J Psychoactive Drugs       Date:  2000 Oct-Dec

7.  Safety, tolerability, and efficacy of orally administered cannabinoids in MS.

Authors:  J Killestein; E L J Hoogervorst; M Reif; N F Kalkers; A C Van Loenen; P G M Staats; R W Gorter; B M J Uitdehaag; C H Polman
Journal:  Neurology       Date:  2002-05-14       Impact factor: 9.910

Review 8.  Disease-modifying drugs for relapsing-remitting multiple sclerosis and future directions for multiple sclerosis therapeutics.

Authors:  R A Rudick
Journal:  Arch Neurol       Date:  1999-09

9.  Cannabis use as described by people with multiple sclerosis.

Authors:  S A Page; M J Verhoef; R A Stebbins; L M Metz; J C Levy
Journal:  Can J Neurol Sci       Date:  2003-08       Impact factor: 2.104

10.  Cannabis for chronic pain: case series and implications for clinicians.

Authors:  Mark A Ware; Ann Gamsa; Jan Persson; Mary-Ann Fitzcharles
Journal:  Pain Res Manag       Date:  2002       Impact factor: 3.037

View more
  3 in total

Review 1.  In the weeds: a baseline view of cannabis use among legalizing states and their neighbours.

Authors:  Rosalie Liccardo Pacula; Mireille Jacobson; Ervant J Maksabedian
Journal:  Addiction       Date:  2016-01-26       Impact factor: 6.526

2.  Marijuana as a Substitute for Prescription Medications: A Qualitative Study.

Authors:  Alana Mercurio; Elizabeth R Aston; Kasey R Claborn; Katherine Waye; Rochelle K Rosen
Journal:  Subst Use Misuse       Date:  2019-06-10       Impact factor: 2.164

3.  Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study.

Authors:  Joan L Bottorff; Laura J L Bissell; Lynda G Balneaves; John L Oliffe; N Rielle Capler; Jane Buxton
Journal:  Harm Reduct J       Date:  2013-02-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.